AACR Annual Meeting 2023: Phase III Immunotherapy Trials Offer Hope for Patients With Lung, Liver, and Biliary Tract Cancers
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
How the latest clinical therapies are helping patients and laboratory research informing future treatments.
The 2020 death of actor Chadwick Boseman shocked the public, sparking grief in those who revered his portrayal of...
The immune system is designed to operate like a well-oiled machine. With a myriad of distinct cell types, a...
Guest Post by William G. Nelson, MD, PhD, Editor-in-Chief, Cancer Today Many argue that warfare metaphors, with winners and losers,...